NM_012144.4(DNAI1):c.1877C>T (p.Ala626Val) AND Primary ciliary dyskinesia

Germline classification:: Likely benign (2 submissions)
Last evaluated:: Jan 22, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000864823.11

Allele description [Variation Report for NM_012144.4(DNAI1):c.1877C>T (p.Ala626Val)]

NM_012144.4(DNAI1):c.1877C>T (p.Ala626Val)

Gene:

DNAI1:dynein axonemal intermediate chain 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

9p13.3

Genomic location:

Preferred name:

NM_012144.4(DNAI1):c.1877C>T (p.Ala626Val)

HGVS:

NC_000009.12:g.34517343C>T
NG_008127.1:g.63531C>T
NM_001281428.2:c.1889C>T
NM_012144.4:c.1877C>TMANE SELECT
NP_001268357.1:p.Ala630Val
NP_036276.1:p.Ala626Val
NC_000009.11:g.34517341C>T
NM_012144.3:c.1877C>T

Protein change:

A626V

Links:

dbSNP: rs565034311

NCBI 1000 Genomes Browser:

rs565034311

Molecular consequence:

NM_001281428.2:c.1889C>T - missense variant - [Sequence Ontology: SO:0001583]
NM_012144.4:c.1877C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Primary ciliary dyskinesia
Synonyms:: Ciliary dyskinesia
Identifiers:: MONDO: MONDO:0016575; MedGen: C0008780; OMIM: PS244400; Human Phenotype Ontology: HP:0012265

Recent activity

Clear Turn Off Turn On

PREDICTED: E3 ubiquitin-protein ligase CBL [Pelecanus crispus]
PREDICTED: E3 ubiquitin-protein ligase CBL [Pelecanus crispus]
gi|694672785|ref|XP_009489949.1|

Protein
envelope glycoprotein, partial [Human immunodeficiency virus 1]
envelope glycoprotein, partial [Human immunodeficiency virus 1]
gi|262070306|gb|ACY08638.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001005683	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jan 22, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV001462494	Natera, Inc.	no assertion criteria provided	Likely benign (Jan 10, 2020)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001005683

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jan 22, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001462494

Natera, Inc.

no assertion criteria provided

Likely benign
(Jan 10, 2020)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001005683.6

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Natera, Inc., SCV001462494.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 13, 2024

ClinVar

Relating variation to medicine